Abstract 2584: Tandutinib inhibits the PI3 Kinase/Akt/mTOR signaling pathway to inhibit colon cancer growth.
Keyword(s):
2013 ◽
Vol 12
(5)
◽
pp. 598-609
◽
Keyword(s):
2013 ◽
Vol 18
(3)
◽
pp. 264-270
◽
Keyword(s):
2006 ◽
Vol 72
(8)
◽
pp. 992-1000
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):